Medicare Beneficiaries can Receive Monoclonal Antibodies with No Cost Share

On November 10, 2020, the Centers for Medicare & Medicaid Services (CMS) announced  that Medicare beneficiaries can receive coverage of monoclonal antibodies to treat COVID-19 with no cost-sharing during the public health emergency. This treatment can be received in doctors’ offices, nursing homes, infusion centers, and hospitals, as long as safety conditions can be met. CMS intends to issue billing and coding instructions to providers for these treatments soon. Healthcare providers who intend to administer these treatments must be enrolled to administer COVID-19 vaccines. More information is available in the related instructions.